Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 72Esophageal Squamous Cell Carcinoma 41Carcinoma, Non-Small-Cell Lung 33Stomach Neoplasms 31Colorectal Neoplasms 30Ovarian Neoplasms 25Pancreatic Neoplasms 22Adenocarcinoma Of Esophagus 16Breast Neoplasms 15Lung Neoplasms 13Neoplasm Metastasis 11Squamous Cell Carcinoma of Head and Neck 10Sarcoma 10Melanoma 10Liver Neoplasms 10Endometrial Neoplasms 10Colonic Neoplasms 10Neoplasms 9Hepatoblastoma 8Head and Neck Neoplasms 8Cholangiocarcinoma 8Carcinoma, Hepatocellular 8Uterine Cervical Neoplasms 7Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Carcinoma, Renal Cell 7Anus Neoplasms 7Rectal Neoplasms 6Carcinoma, Squamous Cell 6Testicular Neoplasms 5

Interventions

trifluridine tipiracil drug combination 1romidepsin 1futibatinib 1cabozantinib 1atezolizumab 1Trabectedin 1TAS-116 1Ramucirumab 1Imatinib Mesylate 1HhAntag691 1Gemcitabine 1Fluorouracil 1Dasatinib 1Cisplatin 1Carboplatin 1Bevacizumab 14-(2-fluoro-4-((((2-phenylacetyl)amino)thioxomethyl)amino)phenoxy)-7-methoxy-N-methyl-6-quinolinecarboxamide 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Carboplatin × Gastrointestinal × Clear all
NCT04999761 2024-09-25

AB122 Platform Study

Taiho Pharmaceutical Co., Ltd.

Phase 1 Recruiting
917 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡